Table 1.
Participants N (%) |
|
---|---|
Sex (N = 370) | |
Male | 227 (61.4%) |
Race/ethnicity (N =311) | |
White | 145 (46.6%) |
Hispanic | 62 (19.9%) |
Black | 70 (22.5%) |
Other | 34 (10.9%) |
Clinical pattern of NS (N = 354) | |
Steroid sensitive-infrequently relapsing | 104 (29.4%) |
Steroid sensitive-frequently relapsing or | 146 (41.2%) |
steroid dependent | 99 (28.0%) |
Steroid-resistant | 5 (1.4%) |
Congenital or infantile | |
Biopsy diagnosis (N = 370) | |
Minimal change disease (± mild mesangial | 111 (30.0%) |
hypercellularity) | 85 (23.0%) |
FSGS or FGGS | 24 (6.5%) |
Membranous, MPGN, others | 150 (40.5%) |
No biopsy |
FGGS focal global glomerulosclerosis, FSGS focal segmental glomerulosclerosis, MPGN membranoproliferative glomerulonephritis, NS nephrotic syndrome